FTC Commissioner Slams Authorized Generics
Patent litigation that ends in authorized generic agreements poses a significant threat to competition in the pharmaceutical industry, said Federal Trade Commissioner Jon Leibowitz at a Thursday hearing before the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article